HCA Midwest Kansas City/ Sarah Cannon — Kansas City, Missouri

HCA Midwest Kansas City/ Sarah Cannon is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

HCA Midwest Kansas City/ Sarah Cannon has participated in 1 clinical trials.

Therapeutic areas: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Kansas City/ Sarah Cannon?

HCA Midwest Kansas City/ Sarah Cannon has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Kansas City/ Sarah Cannon conducted?

HCA Midwest Kansas City/ Sarah Cannon has 1 clinical trials on record. Their work covers Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is HCA Midwest Kansas City/ Sarah Cannon accredited by Crixeo Health?

HCA Midwest Kansas City/ Sarah Cannon has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Kansas City/ Sarah Cannon?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.